Compound Detail
CHEMBL173434
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL173434 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BPEUBRDKZSMJNC-SREVYHEPSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
259.3
MW (Da)
1.85
ALogP
5
HBA
0
HBD
49.0
PSA (Ų)
0.61
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.05
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Homo sapiens CHEMBL372 | IC50 | 5.05 | 5.05 | 8900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Homo sapiens | IC50 | = | 8900.0 | nM | 5.05 | In vitro inhibition of ADP-induced aggregation of human platelet rich plasma in ... | 2704033 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 2704033 | 10.1021/jm00124a027 | Homo sapiens | 2 |
Data from ChEMBL 36 via Core Engine